Developing better ways to measure eye inflammation in uveitis
Official title: UCLA/American Uveitis Society 2nd International Workshop on Objective Measures for Use in Clinical Trials
Funded at University of California Los Angeles · NIH-11000707 · Data updated 2026-11-12
This study is all about finding better ways to measure eye inflammation caused by uveitis, and it's designed for early career researchers and trainees who want to work with experts to improve how we track and treat this condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project start | August 1, 2024 |
| Project end | July 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $32,000 |
| NIH project number | 1R13EY036717-01 |
| Project ID | NIH-11000707 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with uveitis or those at risk of developing inflammatory eye diseases.
✕Less likely to help
Patients with non-inflammatory eye conditions or those not diagnosed with uveitis may not benefit from this research.
What this research studies
This research focuses on creating objective measures to detect and monitor intraocular inflammation associated with uveitis. It involves a workshop where early career researchers and trainees will collaborate with experts in the field to discuss and refine these measurement techniques. Participants will review existing methods, explore new techniques for quantifying inflammation, and work towards standardizing these measures for clinical trials. The workshop aims to foster collaboration among ophthalmologists, clinical trialists, and industry representatives to advance the understanding and treatment of inflammatory eye diseases.
Why it matters
Potential benefit: If successful, this research could lead to improved detection and monitoring of uveitis, potentially reducing the risk of blindness for patients.
How similar studies have gone: Previous workshops and research in this area have shown promise in developing standardized measures for clinical trials, indicating a potential for success in this ongoing effort.
Where this research is happening
-
University of California Los Angeles
Los Angeles, United States Active
Researchers
- Principal investigator: Tsui, Edmund — University of California Los Angeles
- Study coordinator: Tsui, Edmund
Related research
Other NIH-funded projects on the same topics.
-
Adalimumab Dose Adjustment for Pediatric Uveitis in JIA
A pediatric study will test whether lowering how often kids with juvenile idiopathic arthritis–related uveitis take adalimumab can keep inflammation controlled while reducing side effects and cost.
-
Changing adalimumab dosing for children with juvenile arthritis–related eye inflammation
This project tries to see if giving lower or less frequent doses of adalimumab can keep eye inflammation under control in children with juvenile idiopathic arthritis.
-
Systemic and topical antiviral treatment for CMV anterior uveitis (STACCATO)
A new NIH-supported effort will test how well oral and eye-applied antiviral medicines control CMV-related anterior uveitis in affected patients.
-
Systemic and topical antiviral treatment for CMV anterior uveitis in patients
A patient-friendly look at using antiviral medicines to treat CMV-related eye inflammation and protect vision.
-
Systemic and topical antiviral treatment for CMV anterior uveitis
This project tests how oral and eye-drop antiviral medicines can help prevent vision loss from CMV-related eye inflammation in people with anterior uveitis.
-
Systemic and topical antiviral control of CMV anterior uveitis: TreatmentOutcomes
A patient-focused look at how CMV eye inflammation in adults could be treated with pills, eye drops, or other strategies to prevent vision loss.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.